Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Pristimerin induces apoptosis by targeting the proteasome in prostate cancer cells.

Pristimerin induces apoptosis by targeting the proteasome in prostate cancer cells. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Pristimerin induces apoptosis by targeting the proteasome in prostate cancer cells. Abstract Text:

    huanjie yangHuanjie Yang,kristin r landis-piwowarKristin R Landis-Piwowar,dayan luDayan Lu,ping yuanPing Yuan,lihua liLihua Li,g prem-veer reddyG Prem-Veer Reddy,xiao yuanXiao Yuan,q ping douQ Ping Dou,huanjie yangHuanjie Yang,kristin r landis-piwowarKristin R Landis-Piwowar,dayan luDayan Lu,ping yuanPing Yuan,lihua liLihua Li,g prem-veer reddyG Prem-Veer Reddy,xiao yuanXiao Yuan,q ping douQ Ping Dou,

    Pristimerin is a natural product derived from the Celastraceae and Hippocrateaceae families that were used as folk medicines for antiinflammation in ancient times. Although it has been shown that pristimerin induces apoptosis in breast cancer cells, the involved mechanism of action is unknown. The purpose of the current study is to investigate the primary target of pristimerin in human cancer cells, using prostate cancer cells as a working model. Nucleophilic susceptibility and in silico docking studies show that C(6) of pristimerin is highly susceptible towards a nucleophilic attack by the hydroxyl group of N-terminal threonine of the proteasomal chymotrypsin subunit. Consistently, pristimerin potently inhibits the chymotrypsin-like activity of a purified rabbit 20S proteasome (IC(50) 2.2 micromol/L) and human prostate cancer 26S proteasome (IC(50) 3.0 micromol/L). The accumulation of ubiquitinated proteins and three proteasome target proteins, Bax, p27 and IkappaB-alpha, in androgen receptor (AR)-negative PC-3 prostate cancer cells supports the conclusion that proteasome inhibition by pristimerin is physiologically functional. This observed proteasome inhibition subsequently led to the induction of apoptotic cell death in a dose- and kinetic-dependent manner. Furthermore, in AR-positive, androgen-dependent LNCaP and AR-positive, androgen-independent C4-2B prostate cancer cells, proteasome inhibition by pristimerin results in suppression of AR protein prior to apoptosis. Our data demonstrate, for the first time, that the proteasome is a primary target of pristimerin in prostate cancer cells and inhibition of the proteasomal chymotrypsin-like activity by pristimerin is responsible for its cancer cell death-inducing property. J. Cell. Biochem. 103: 234-244, 2008. (c) 2007 Wiley-Liss, Inc.

    Pristimerin induces apoptosis by targeting the proteasome in prostate cancer cells. Publishing Authors By Initials

    h yangH Yang,kr landis-piwowarKR Landis-Piwowar,d luD Lu,p yuanP Yuan,l liL Li,gp reddyGP Reddy,x yuanX Yuan,qp douQP Dou,h yangH Yang,kr landis-piwowarKR Landis-Piwowar,d luD Lu,p yuanP Yuan,l liL Li,gp reddyGP Reddy,x yuanX Yuan,qp douQP Dou,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Pristimerin induces apoptosis by targeting the proteasome in prostate cancer cells. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Journal of cellular biochemistry

    VOLUME: 103

    Page Numbers: 234-44

    Journal Abbreviation: J. Cell. Biochem.

    ISSN: 0730-2312

    DAY: 1

    MONTH: Jan

    YEAR: 2008

    Pristimerin induces apoptosis by targeting the proteasome in prostate cancer cells. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 8205768

    Pristimerin induces apoptosis by targeting the proteasome in prostate cancer cells. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Pristimerin induces apoptosis by targeting the proteasome in prostate cancer cells. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Pristimerin induces apoptosis by targeting the proteasome in prostate cancer cells.

    AFFILIATION: The Prevention Program, Barbara Ann Karmanos Cancer Institute, School of Medicine, Wayne State University, Detroit, Michigan.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: J Cell Biochem

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Pristimerin induces apoptosis by targeting the proteasome in prostate cancer cells Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News